The place of thalidomide in the treatment of multiple myeloma
Thalidomide represents the first attempt in multiple myeloma (MM) patients to overcome resistance to chemotherapy through a biological agent. The exciting results reported in the first study by Singhal et al. in 1999 [1] led to several other studies which aimed to evaluate its efficacy in different...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2011-12-01
|
| シリーズ: | Oncology Reviews |
| 主題: | |
| オンライン･アクセス: | http://oncologyreviews.org/index.php/or/article/view/157 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|